October 8th 2025, 7:04pm
The FDA has approved Libtayo for the postsurgical treatment of adults with cutaneous squamous cell carcinoma.
October 8th 2025, 5:00pm
At the age of 34, I received the biggest news of my life, which was my diagnosis with colon cancer. I remember that day like it was yesterday.
October 8th 2025, 4:00pm
Although death rates continue to decline each year, prostate cancer cases are increasing, especially those diagnosed at advanced stages.
October 8th 2025, 3:04pm
The FDA granted fast track status to UB-VV111 for patients with relapsed or refractory large B-cell lymphoma or chronic lymphocytic leukemia.
October 8th 2025, 1:00pm
Dr. Evan Garfein said 3D printing and tissue-engineered implants may make breast reconstruction safer, more personalized and less physically taxing.
October 7th 2025, 9:00pm
It’s October, and social media sites are full of vendors selling merchandise featuring pink ribbons. But here's the thing...
LiveLung, a nonprofit organization dedicated to supporting lung cancer patients, invites the Charlotte cancer community to its monthly educational meeting.
October 7th 2025, 8:00pm
Dr. Nicolas Girard discussed the current treatment options for patients with EGFR-mutant lung cancer, including emerging combination regimens.
October 7th 2025, 7:00pm
After Barbara Tatham’s passing from metastatic sarcoma, her sister and friend completed her memoir, highlighting caregiving, resilience and family support.
October 7th 2025, 5:00pm
As a Lynch syndrome previvor, I felt that the film “Love, Danielle” struck a deeply personal chord.
Voranigo Continues to Benefit Patients With Grade 2 IDH-Mutated Glioma
Experts Urge Greater Awareness and Support as Liver Cancer Month Ends
Finding Humor in a Cancer Journey
Pancreatic Cancer on the Rise Among Younger Adults